Neuromuscular junction

Wednesday, September 14, 2022

PARALLEL 1

• 14-PM-Parallel-1 • 4:30 PM > 6:00 PM • Neuromuscular junction • Apollon Auditorium

4:30 PM • S13L1 • New treatments for autoimmune myasthenia gravis > E. Emilien DELMONT 5:00 PM • S13L2 • Use of human pluripotent stem cells for Neuromuscular Disorders > C. Cecile MARTINAT 5:30 PM • S13L3 • Targeting the neuromuscular junction (NMJ) to treat congenital myasthenic syndromes and inherited motor neuropathies with NMJ dysfunction > S. Sally SPENDIFF